|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/00 | |||
| A61P 31/18 |
| (11) | Patento numeris | 3183270 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15832985.4 |
| Europos patento paraiškos padavimo data | 2015-08-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-06-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/046160 |
| Data | 2015-08-20 |
| (87) | Numeris | WO 2016/029049 |
| Data | 2016-02-25 |
| (30) | Numeris | Data | Šalis |
| 201462039620 P | 2014-08-20 | US | |
| 201562192941 P | 2015-07-15 | US |
| (72) |
SCHOOLEY, Robert T., US
POURHASSAN, Nader Z., US
|
| (73) |
CytoDyn Inc.,
1111 Main Street Suite 660, Vancouver, WA 98660,
US
|
| (54) | HIV ANTIBODY THERAPY AS TREATMENT SUBSTITUTE |
| HIV ANTIBODY THERAPY AS TREATMENT SUBSTITUTE |